By the use of a unique panel of R5 isolates acquired sequentially before and after AIDS onset at severe immunodeficiency we here reveal that end-stage R5 viruses display increased level of sensitivity to neutralization from the TriMab mix of broadly neutralizing monoclonal antibodies (MAbs) IgGb12, 2F5 and 2G12
By the use of a unique panel of R5 isolates acquired sequentially before and after AIDS onset at severe immunodeficiency we here reveal that end-stage… Read More »By the use of a unique panel of R5 isolates acquired sequentially before and after AIDS onset at severe immunodeficiency we here reveal that end-stage R5 viruses display increased level of sensitivity to neutralization from the TriMab mix of broadly neutralizing monoclonal antibodies (MAbs) IgGb12, 2F5 and 2G12